Clinipace

Based on our tremendous growth in new clients and projects over the past few years Clinipace Worldwide, a global full-service CRO, has been recognized as a Top 100 North Carolina Small Business  for 2010 by Business Leader magazine, a leading business publication focused on the companies, leaders and trends in the North Carolina business community.

Clinipace Worldwide ranked #7 in North Carolina, and #2 in the Research Triangle Park, up from #52 in 2009.

Business Leader’s list of Top 100 North Carolina Small Businesses is comprised of firms with 100 employees or less that do the majority of their business in North Carolina. Each company’s one-year and five-year revenue growth, business achievements and community involvement were evaluated during the selection process.

We’re expanding to enhance our global clinical operations capabilities and oncology therapeutic practice

On October 26th, 2009, Clinipace closed its acquisition of Worldwide Clinical Research, Inc. (WWCR), a Midwest-based CRO specializing in the management of clinical studies for biotechnology and pharmaceutical companies. With the acquisition, Clinipace has changed its name to Clinipace Worldwide.

“Vaccinogen selected Clinipace Worldwide for its upcoming global clinical trial due, in part, to the combined strength of both companies and experience managing phase 3 international oncology trials,” said Michael G. Hanna,” Jr., Ph.D., Founder, Chairman & CEO of Vaccinogen. We are confident their therapeutic and operations experts, along with their technology platform, will enable us to centrally manage a very complex protocol with some very unique requirements.”

Combined, the companies have managed over 70 contract research projects conducted globally at almost 3,000 sites with 100,000 patients. With specific expertise in oncology, among other therapeutic areas, the company will offer fully-integrated technology-based clinical research solutions and services to growth-oriented and mid-tier biopharmaceutical and medical device firms.

We welcome more than 30 employees to the company and our headquarters will remain in Research Triangle Park, NC with additional domestic operations in Overland Park, KS, and South American operations based in Sao Paulo, Brazil, Buenos Aires, Argentina, and Lima, Peru.

Barbara Geiger, president and CEO of WWCR, will transition to Executive Vice President of Clinical Operations and will be responsible for directing all clinical operations for Clinipace Worldwide, Inc. from the Overland Park, KS office.

Click here to contact us for more information